Survey of Victorian ophthalmologists who use ranibizumab to treat age-related macular degeneration: to identify current practice and modifiable risk factors relevant to post-injection endophthalmitis-Reference-Cited by-同舟云学术

Survey of Victorian ophthalmologists who use ranibizumab to treat age-related macular degeneration: to identify current practice and modifiable risk factors relevant to post-injection endophthalmitis

Published:2014-10-02 Issue:3 Volume:43 Page:277-279
ISSN:1442-6404
Container-title:Clinical & Experimental Ophthalmology
language:en
Short-container-title:Clin Experiment Ophthalmol

Author:

Buck Danielle A¹,Dawkins Rosie¹,Kawasaki Ryo²³,Sandhu Sukhpal S¹³⁴,Allen Penelope J¹³⁴

Affiliation:

1. Royal Victorian Eye and Ear Hospital; Melbourne Victoria Australia

2. Yamagata University Faculty of Medicine; Yamagata Japan

3. Centre for Eye Research Australia; Melbourne Victoria Australia

4. University of Melbourne; Melbourne Victoria Australia

Publisher

Wiley

Subject

Ophthalmology

Reference5 articles.

1. Saving money on the PBS: ranibizumab or bevacizumab for neovascular macular degeneration?;Harvey;Med J Aust,2011

2. Endophthalmitis after intravitreal injection: the importance of viridans streptococci;Chen;Retina,2011

3. Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes;Lyall;Eye,2012

4. Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies;McCannel;Retina,2011

5. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents;Shah;Ophthalmology,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statistical Analysis of Ceiling and Floor Effects in Medical Trials;Applied Biosciences;2023-12-04

2. Application of Machine Learning to Ranking Predictors of Anti-VEGF Response;Life;2022-11-18

3. Current Practice Preferences and Safety Protocols for Intravitreal Injection of Anti–Vascular Endothelial Growth Factor Agents;Ophthalmology Retina;2019-08

4. Endophthalmitis Following Intravitreal Injections Performed in the Office Versus Operating Room Setting;Current Ophthalmology Reports;2019-04-09

5. The effect of diluting povidone-iodine on bacterial growth associated with speech;BMC Ophthalmology;2019-02-26